These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11000956)

  • 21. The natural history and incidence of Yersinia pestis and prospects for vaccination.
    Williamson ED; Oyston PCF
    J Med Microbiol; 2012 Jul; 61(Pt 7):911-918. PubMed ID: 22442294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yersinia pestis: still a plague in the 21st century.
    Josko D
    Clin Lab Sci; 2004; 17(1):25-9. PubMed ID: 15011977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The plague in Madagascar: epidemiologic data from 1989 to 1995 and the national control program].
    Champetier de Ribes G; Rasoamanana B; Randriambelosoa J; Rakoto LJ; Rabescn D; Chanteau S
    Sante; 1997; 7(1):53-60. PubMed ID: 9172878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Was Yersinia pestis the cause of the black death?].
    Walløe L
    Tidsskr Nor Laegeforen; 2007 Dec; 127(24):3193. PubMed ID: 18084357
    [No Abstract]   [Full Text] [Related]  

  • 27. Plague, policy, saints and terrorists: a historical survey.
    Lippi D; Conti AA
    J Infect; 2002 May; 44(4):226-8. PubMed ID: 12099728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plague history: Yersin's discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines.
    Butler T
    Clin Microbiol Infect; 2014 Mar; 20(3):202-9. PubMed ID: 24438235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The plague of the third pandemic and its current remergence].
    Barry S
    Vesalius; 2008 Dec; 14(2):69-73. PubMed ID: 19579344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resurgence of the plague in the Ikongo district of Madagascar in 1998. 1. Epidemiological aspects in the human population].
    Migliani R; Ratsitorahina M; Rahalison L; Rakotoarivony I; Duchemin JB; Duplantier JM; Rakotonomenjanahary J; Chanteau S
    Bull Soc Pathol Exot; 2001 May; 94(2):115-8. PubMed ID: 11475028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends of Human Plague, Madagascar, 1998-2016.
    Andrianaivoarimanana V; Piola P; Wagner DM; Rakotomanana F; Maheriniaina V; Andrianalimanana S; Chanteau S; Rahalison L; Ratsitorahina M; Rajerison M
    Emerg Infect Dis; 2019 Feb; 25(2):220-228. PubMed ID: 30666930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular history of plague.
    Drancourt M; Raoult D
    Clin Microbiol Infect; 2016 Nov; 22(11):911-915. PubMed ID: 27615720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resurgence of the plague in the Ikongo district of Madagascar in 1998. 2. Reservoirs and vectors implicated].
    Duplantier JM; Duchemin JB; Ratsitorahina M; Rahalison L; Chanteau S
    Bull Soc Pathol Exot; 2001 May; 94(2):119-22. PubMed ID: 11475029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plague: the dreadful visitation occupying the human mind for centuries.
    Khan IA
    Trans R Soc Trop Med Hyg; 2004 May; 98(5):270-7. PubMed ID: 15109549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Plague Doctor of Venice.
    Mussap CJ
    Intern Med J; 2019 May; 49(5):671-676. PubMed ID: 31083805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genesis of the anti-plague system: the Tsarist period.
    Melikishvili A
    Crit Rev Microbiol; 2006; 32(1):19-31. PubMed ID: 16610335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
    Reed DS; Martinez MJ
    Vaccine; 2006 Mar; 24(13):2283-9. PubMed ID: 16377037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.